|
Volumn 33 Suppl 1, Issue , 2006, Pages 224-229
|
Radiotherapy combined with S-1 and cisplatin for locally advanced and metastatic esophageal cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
OXONIC ACID;
S 1 (COMBINATION);
TEGAFUR;
AGED;
ANEMIA;
ARTICLE;
CANCER STAGING;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
DRUG COMBINATION;
ESOPHAGUS TUMOR;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PROSPECTIVE STUDY;
RADIATION DOSE;
SURVIVAL RATE;
THROMBOCYTOPENIA;
AGED;
AGED, 80 AND OVER;
ANEMIA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
COMBINED MODALITY THERAPY;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
ESOPHAGEAL NEOPLASMS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
OXONIC ACID;
PROSPECTIVE STUDIES;
RADIOTHERAPY DOSAGE;
SURVIVAL RATE;
TEGAFUR;
THROMBOCYTOPENIA;
|
EID: 33747387940
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|